IJCS | Volume 31, Nº2, Março / Abril 2018

187 7. World Health Organization. (WHO). Control of Chagas' disease: second report of theWHOexpert committee. Geneva; 2002. (WHO tecnical report series, 905). 8. Marin-Neto JA, Almeida Filho OC, Pazin-Filho A, Maciel BC. [Indeterminate form of Chagas' disease: proposal of new diagnostic criteria and perspectives for early treatment of cardiomyopathy]. Arq Bras Cardiol. 2002;79(6):623-7. PMID: 12532246.. 9. RassiJrA,RassiA,Marin-NetoJA.Chagasheartdisease:pathophysiologic mechanisms, prognostic factors and risk stratification. Mem Inst Oswaldo Cruz. 2009;104 Suppl 1:152-8. doi: http://dx.doi.org/10.1590/S0074- 02762009000900021. 10. Coura JR, De Abreu LL, Dubois LE, Lima FD, De Arruda Junior E, Willcox HP, et al. [Morbidity of Chagas' disease. II - Sectional studies in 4 field areas in Brazil]. Mem Inst Oswaldo Cruz. 1984;79(1):101-24. doi: http:// dx.doi.org/10.1590/S0074-02761984000100012. 11. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV. Pathogenesis of chronic Chagas heart disease. Circulation. 2007;115(9):1109-23. doi: 10.1161/CIRCULATIONAHA.106.624296. 12. Dias E, Laranja FS, Miranda A, Nobrega G. Chagas' disease; a clinical, epidemiologic, and pathologic study. Circulation. 1956;14(6):1035-60. PMID: 13383798. 13. Coura JR, Vinas PA, Brum-Soares LM, de Sousa AS, Xavier SS. Morbidity of Chagas heart disease in the microregion of Rio Negro, Amazonian Brazil: a case-control study. Mem Inst Oswaldo Cruz. 2013;108(8):1009- 13. doi: http://dx.doi.org/10.1590/0074-0276130425. 14. Souza FF, Castro ES, Marin Neto JA, Sankarankutty AK, Teixeira AC, Martinelli AL, et al. Acute chagasic myocardiopathy after orthotopic liver transplantation with donor and recipient serologically negative for Trypanosoma cruzi: a case report. Transplant Proc. 2008;40(3):875-8. doi: 10.1016/j.transproceed.2008.02.032. 15. Wegner DH, Rohwedder RW. The effect of nifurtimox in acute Chagas' infection. Arzneimittelforschung. 1972;22(9):1624-35. PMID: 4630485. 16. Kirchhoff LV. Chagas disease. American trypanosomiasis. Infect Dis Clin North Am. 1993;7(3):487-502. PMID: 8254156. 17. Pazin-Filho A, Romano MM, Almeida-Filho OC, Furuta MS, Viviani LF, Schmidt A, et al. Minor segmental wall motion abnormalities detected in patients with Chagas' disease have adverse prognostic implications. Braz J Med Biol Res. 2006;39(4):483-7. doi: http://dx.doi.org/10.1590/ S0100-879X2006000400008. 18. Garcia-Alvarez A, Sitges M, Regueiro A, Poyatos S, Jesus Pinazo M, Posada E, et al. Myocardial deformation analysis in Chagas heart disease with the use of speckle tracking echocardiography. J Card Fail. 2011;17(12):1028-34. doi: 10.1016/j.cardfail.2011.08.007. 19. Dias JC. The indeterminate form of human chronic Chagas' disease: a clinical epidemiological review. Rev Soc Bras Med Trop. 1989;22(3):147- 56. http://dx.doi.org/10.1590/S0037-86821989000300007. 20. Marin-Neto JA, Simoes MV, Sarabanda AV. Forma crônica cardíaca. Trypanosoma Cruzi e Doença de Chagas. 2ª ed. São Paulo: Guanabara- Koogan; 2000. p. 266-96. 21. Ianni BM, Arteaga E, Frimm CC, Pereira Barretto AC, Mady C. Chagas' heart disease: evolutive evaluation of electrocardiographic and echocardiographic parameters in patients with the indeterminate form. Arq Bras Cardiol. 2001;77(1):59-62. doi: http://dx.doi.org/10.1590/ S0066-782X2001000700006. 22. Rassi A Jr, Rassi SG, Rassi A. Sudden death in Chagas' disease. Arq Bras Cardiol. 2001;76(1):75-96. doi: http://dx.doi.org/10.1590/S0066- 782X2001000100008. 23. Carod-Artal FJ, Vargas AP, Horan TA, Nunes LG. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke. 2005;36(5):965-70. doi: 10.1161/01. STR.0000163104.92943.50. 24. Maguire JH, Hoff R, Sherlock I, Guimaraes AC, Sleigh AC, Ramos NB, et al. Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community. Circulation. 1987;75(6):1140-5. PMID: 3552307. 25. Forichon E. Contribution aux estimations de morbité et de mortalité dans la maladie de Chagas. Toulouse (France): Univers. Paul Sabatier; 1974. 26. Nunes MC, Dones W, Morillo CA, Encina JJ, Ribeiro AL; Council on Chagas Disease of the Interamerican Society of Cardiology. Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol. 2013;62(9):767-76. doi: 10.1016/j.jacc.2013.05.046. 27. Manzullo EC, Darraidou MA, Libonatti O, Rozlosnik J, Bazzano AC. Estudio longitudinal de la cardiopatia chagasica cronica. [Tese]. Centro de Chagas de la Catedra de Enfermedades Infecciosas de la Facultad de Ciencias Medicas de Buenos Aires. Buenos Aires; 1982. 28. Chagas C. A short chronicle of the discovery of Chagas' disease. Pacing Clin Electrophysiol. 1988;11(7):1108-13. PMID: 2457892. 29. Samuel J, Oliveira M, Correa De Araujo RR, Navarro MA, Muccillo G. Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease. Am J Cardiol. 1983;52(1):147-51. PMID: 6858902. 30. Nunes Mdo C, Barbosa MM, Rocha MO. Peculiar aspects of cardiogenic embolism in patients with Chagas' cardiomyopathy: a transthoracic and transesophageal echocardiographic study. J Am Soc Echocardiogr. 2005;18(7):761-7. doi: 10.1016/j.echo.2005.01.026. 31. Carod-Artal FJ, Gascon J. Chagas disease and stroke. Lancet Neurol. 2010;9(5):533-42. doi: 10.1016/S1474-4422(10)70042-9. 32. Cardoso RN, Macedo FY, GarciaMN, Garcia DC, BenjoAM, Aguilar D, et al. Chagas' cardiomyopathy is associatedwith higher incidence of stroke: a meta-analysis of observational studies. J Card Fail. 2014;20(12):931-8. doi: 10.1016/j.cardfail.2014.09.003. 33. Sousa AS, Xavier SS, Freitas GR, Hasslocher-Moreno A. Prevention strategies of cardioembolic ischemic stroke in Chagas' disease. Arq Bras Cardiol. 2008;91(5):306-10. doi: http://dx.doi.org/10.1590/S0066- 782X2008001700004. 34. Rassi Junior A, Gabriel Rassi A, Gabriel Rassi S, Rassi Junior L, Rassi A. [Ventricular arrhythmia in Chagas disease. Diagnostic, prognostic, and therapeutic features]. Arq Bras Cardiol.1995;65(4):377-87. PMID: 8728815. 35. SarabandaAV, Sosa E, SimoesMV, FigueiredoGL, PintyaAO,Marin-Neto JA. Ventricular tachycardia in Chagas' disease: a comparison of clinical, angiographic, electrophysiologic and myocardial perfusion disturbances between patients presentingwith either sustained or nonsustained forms. Int J Cardiol. 2005;102(1):9-19. doi: 10.1016/j.ijcard.2004.03.087. 36. Rochitte CE, Oliveira PF, Andrade JM, Ianni BM, Parga JR, Avila LF, et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol. 2005;46(8):1553-8. doi: 10.1016/j.jacc.2005.06.067. 37. Mello RP, Szarf G, Schvartzman PR, Nakano EM, EspinosaMM, Szejnfeld D, et al. Delayed enhancement cardiac magnetic resonance imaging can identify the risk for ventricular tachycardia in chronic Chagas' heart disease. Arq Bras Cardiol. 2012;98(5):421-30. doi: http://dx.doi . org/10.1590/S0066-782X2012005000031. 38. Schmidt A, Romano MM, Maciel BC, Marin-Neto JA. Cardiac magnetic resonanceimagingforsuddencardiacdeath:muchmorethananothermethod tomeasure LVEF. Current Cardiovascular Imaging Reports. 2013;6(6):431-4. 39. Miranda CH, Figueiredo AB, Maciel BC, Marin-Neto JA, Simoes MV. Sustained ventricular tachycardia is associatedwith regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy. J Nucl Med. 2011;52(4):504-10. doi: 10.2967/jnumed.110.082032. 40. Mendoza I, Camardo J, Moleiro F, Castellanos A, Medina V, Gomez J, et al. Sustained ventricular tachycardia in chronic chagasic myocarditis: electrophysiologic and pharmacologic characteristics. Am J Cardiol. 1986;57(6):423-7. PMID: 3946258. Simões et al. Cardiomiopatia da doença de chagas Int J Cardiovasc Sci. 2018;31(2)173-189 Artigo de Revisão